Fatal Gvhd As A Complication of Liver Transplantation for Undetermined Fulminant Hepatic Failure and Associated Aplastic Anemia
Open Access
- 1 November 2006
- journal article
- case report
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 12 (11) , 1693-1697
Abstract
Fulminant hepatic failure of unknown origin is the most common cause of fulminant hepatitis with high incidence of aplastic anaemia. Furthermore, the association of liver failure and aplastic anaemia has an increased mortality rate. In this report we describe a 16-month-old boy who presented with aplastic anaemia preceding a non-A, non-B, non-C fulminant liver failure. He developed severe graft versus host disease (GvHD) after liver transplantation, proven by the presence of donor cells in the peripheral blood and in the skin biopsy. He received conventional therapy (steroids, mycophenolate, anti-IL-2 monoclonal antibodies, anti-thymocyte globulin) without success. In an attempt to obtain T cell depletion and reduce the GvHD, he was treated with Alemtuzumab, a first time use for this indication. Aplastic anaemia was extensively investigated, especially exploring the possibility of primary immunodeficiency and reticular dysgenesis which were excluded based on clinical history. However, another form of primary immunodeficiency could be the cause of the uncontrollable proliferation of the donor lymphocytes derived from the liver transplant. Despite aggressive treatment GvHD progressed and the patient died of multiorgan failure. The majority of authors mention aplastic anaemia as a secondary event post liver transplant, whereas in our view this might be a haematopoietic stem cell disorder preceding fulminant hepatic failure. These patients also need to be evaluated extensively in order to exclude a primary immunodeficiency. The underlying disease will determine the choice of immunosuppressive treatment, especially in case of development of GvHD caused by the transplanted lymphocytes inhabiting the donor liver. Liver Transpl 12:1693–1697, 2006. © 2006 AASLD.Keywords
This publication has 11 references indexed in Scilit:
- Microchimerism after liver transplantation: Absence of rejection without abrogation of anti-donor cytotoxic T-lymphocyte–mediated alloreactivityLiver Transplantation, 2005
- Early Evidence of Bone Marrow Dysfunction in Children with Indeterminate Fulminant Hepatic Failure Who Ultimately Develop Aplastic AnemiaAmerican Journal of Transplantation, 2004
- Long-Term Outcome of Liver Transplantation in Patients With PSC: A Comparative Analysis With PBCAmerican Journal of Gastroenterology, 2004
- Bone Marrow Failure in Children With Acute Liver FailureJournal of Pediatric Gastroenterology and Nutrition, 2000
- Successful cytokine treatment of aplastic anemia following living‐related orthotopic liver transplantation for non‐A, non‐B, non‐C hepatitisClinical Transplantation, 1999
- Orthotopic liver transplantation for acute hepatic failure in childrenTransplant International, 1994
- Aplastic Anemia After Liver Transplantation for Fulminant Liver FailureHepatology, 1994
- Aplastic Anemia and Viral HepatitisJAMA, 1992
- Aplastic Anemia Complicating Orthotopic Liver Transplantation for Non-A, Non-B HepatitisNew England Journal of Medicine, 1988
- Fulminant hepatic failure in childhood: An analysis of 31 casesArchives of Disease in Childhood, 1980